MariMed Q3 adjusted EBITDA $4.7 million
MRMD•MariMed reported Q3 adjusted EBITDA of $4.7 million, revenue of $44.2 million and net income of $3.5 million in losses.
1. Quarterly results
MariMed reported Q3 adjusted net income of $2.3 million in losses and net income of $3.5 million in losses. Gross margin was 39%, adjusted gross margin was 40% and adjusted EBITDA margin was 11%.
